Renalytix Total Current Liabilities vs Retained Earnings Analysis

RNLX Stock  USD 0.14  0.01  7.69%   
Renalytix financial indicator trend analysis is much more than just breaking down Renalytix AI prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Renalytix AI is a good investment. Please check the relationship between Renalytix Total Current Liabilities and its Retained Earnings accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Total Current Liabilities vs Retained Earnings

Total Current Liabilities vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Renalytix AI Total Current Liabilities account and Retained Earnings. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Renalytix's Total Current Liabilities and Retained Earnings is -0.68. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Renalytix AI, assuming nothing else is changed. The correlation between historical values of Renalytix's Total Current Liabilities and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Renalytix AI are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Total Current Liabilities i.e., Renalytix's Total Current Liabilities and Retained Earnings go up and down completely randomly.

Correlation Coefficient

-0.68
Relationship DirectionNegative 
Relationship StrengthWeak

Total Current Liabilities

Total Current Liabilities is an item on Renalytix balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Renalytix AI are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Renalytix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Renalytix's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 21.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 18.7 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses58.3M43.1M29.0M33.2M
Cost Of Revenue2.1M2.7M2.1M1.4M

Renalytix fundamental ratios Correlations

0.340.560.960.94-0.960.040.980.980.770.70.150.40.590.510.880.180.980.910.30.430.640.890.53-0.060.83
0.340.930.090.17-0.14-0.70.380.350.690.670.680.990.850.960.490.920.370.370.990.750.670.50.770.730.05
0.560.930.320.42-0.37-0.680.580.560.860.810.720.920.950.990.710.870.580.590.930.860.750.580.870.590.33
0.960.090.320.95-0.980.270.930.940.610.54-0.040.150.370.270.78-0.080.940.850.040.230.50.820.32-0.280.85
0.940.170.420.95-0.970.030.950.960.760.60.190.20.520.350.870.10.960.960.150.380.440.810.41-0.090.94
-0.96-0.14-0.37-0.98-0.97-0.2-0.97-0.97-0.7-0.5-0.11-0.17-0.44-0.31-0.770.02-0.97-0.88-0.09-0.24-0.55-0.85-0.30.26-0.92
0.04-0.7-0.680.270.03-0.20.00.01-0.53-0.53-0.74-0.61-0.73-0.67-0.37-0.90.0-0.23-0.76-0.8-0.140.05-0.59-0.830.02
0.980.380.580.930.95-0.970.01.00.840.630.280.410.630.540.850.231.00.930.330.420.680.920.48-0.050.88
0.980.350.560.940.96-0.970.011.00.830.620.270.380.620.510.840.21.00.930.310.40.660.910.46-0.070.9
0.770.690.860.610.76-0.7-0.530.840.830.750.710.660.930.810.850.660.840.870.690.750.680.750.680.370.75
0.70.670.810.540.6-0.5-0.530.630.620.750.380.70.830.780.90.650.650.710.680.90.480.550.860.50.42
0.150.680.72-0.040.19-0.11-0.740.280.270.710.380.570.790.690.330.740.270.340.740.690.410.260.50.530.29
0.40.990.920.150.2-0.17-0.610.410.380.660.70.570.810.960.520.880.410.380.960.720.70.550.820.70.04
0.590.850.950.370.52-0.44-0.730.630.620.930.830.790.810.920.770.840.630.680.870.910.650.570.770.570.48
0.510.960.990.270.35-0.31-0.670.540.510.810.780.690.960.920.650.890.540.530.960.820.750.580.870.640.24
0.880.490.710.780.87-0.77-0.370.850.840.850.90.330.520.770.650.490.860.940.480.740.480.710.740.30.74
0.180.920.87-0.080.10.02-0.90.230.20.660.650.740.880.840.890.490.220.350.950.810.430.290.770.880.02
0.980.370.580.940.96-0.970.01.01.00.840.650.270.410.630.540.860.220.930.330.420.670.920.5-0.040.88
0.910.370.590.850.96-0.88-0.230.930.930.870.710.340.380.680.530.940.350.930.350.550.470.80.570.160.89
0.30.990.930.040.15-0.09-0.760.330.310.690.680.740.960.870.960.480.950.330.350.810.610.440.770.770.04
0.430.750.860.230.38-0.24-0.80.420.40.750.90.690.720.910.820.740.810.420.550.810.380.320.830.670.29
0.640.670.750.50.44-0.55-0.140.680.660.680.480.410.70.650.750.480.430.670.470.610.380.680.520.00.4
0.890.50.580.820.81-0.850.050.920.910.750.550.260.550.570.580.710.290.920.80.440.320.680.490.10.68
0.530.770.870.320.41-0.3-0.590.480.460.680.860.50.820.770.870.740.770.50.570.770.830.520.490.620.23
-0.060.730.59-0.28-0.090.26-0.83-0.05-0.070.370.50.530.70.570.640.30.88-0.040.160.770.670.00.10.62-0.22
0.830.050.330.850.94-0.920.020.880.90.750.420.290.040.480.240.740.020.880.890.040.290.40.680.23-0.22
Click cells to compare fundamentals

Renalytix Account Relationship Matchups

Renalytix fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets41.3M102.6M63.3M42.1M8.0M7.6M
Total Current Liabilities3.4M7.3M12.2M16.1M11.5M8.1M
Total Stockholder Equity36.0M95.1M43.2M18.5M(7.9M)(7.5M)
Net Tangible Assets18.8M71.5M30.6M7.0M8.0M7.6M
Net Debt(12.7M)(64.8M)(28.6M)(12.5M)3.9M4.0M
Retained Earnings34.9M3.8M(53.0M)(99.2M)(211.8M)(201.2M)
Cash13.3M65.2M41.3M24.7M4.7M4.4M
Non Current Assets Total22.4M26.6M15.8M13.8M1.9M1.8M
Cash And Short Term Investments14.3M74.5M44.1M26.1M4.7M4.4M
Net Receivables18K1.2M901K776K722K573.3K
Common Stock Shares Outstanding29.5M71.5M73.8M82.2M108.2M69.2M
Liabilities And Stockholders Equity41.3M102.6M63.3M42.1M8.0M7.6M
Non Current Liabilities Total2.0M213K7.9M7.5M4.3M3.6M
Other Stockholder Equity2.8M150.4M164.0M186.5M204.9M116.8M
Total Liab5.3M7.5M20.1M23.7M15.8M11.5M
Net Invested Capital36.2M71.5M42.9M30.4M35.0M38.4M
Short Long Term Debt121K53K4.7M4.5M5.1M5.4M
Total Current Assets18.9M76.0M47.4M28.3M6.1M5.8M
Net Working Capital15.5M59.7M33.0M12.2M14.0M23.7M
Common Stock192K233K241K299K478K265.2K
Other Current Liab271K4.1M4.5M8.6M178K169.1K
Property Plant And Equipment Net945K2.5M3.1M1.2M216K205.2K
Accounts Payable2.9M1.8M2.5M2.9M2.6M2.5M
Non Currrent Assets Other83K(1.1M)1.5M51K1.6M1.7M
Other Assets2.4M7.2M1.2M1.1M1.3M1.2M
Short Term Investments982K9.3M2.7M1.5M1.7M1.6M
Inventory326K353K1.2M718K825.7K562.5K
Other Current Assets4.3M1.2M2.3M1.4M716K1.3M
Property Plant And Equipment Gross945K2.7M3.6M1.2M1.4M1.9M
Accumulated Other Comprehensive Income(1.9M)8.3M(915K)(1.5M)(1.4M)(1.4M)
Capital Stock192K233K228K299K343.9K247.9K
Property Plant Equipment945K2.5M2.6M1.2M1.4M1.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.